Trials / Terminated
TerminatedNCT01222416
PET/CT Evaluation of Treatment Response in Breast Cancer
Positron Emission Tomography (PET)-Computed Tomography (CT) PET/CT Evaluation of Treatment Response in Breast Cancer
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Vanderbilt-Ingram Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to develop Positron Emission Tomography (PET) - Computed Tomography (CT) PET/CT imaging methods for looking at the effects of chemotherapy in breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiopharmaceutical Administration [18F]-FDG | Adult dose: (0.15 mCi/kg ranging from 3 to 16 mCi,route IV. Time interval between administration and scanning: 60 +/- 10minutes post-injection. |
| RADIATION | Radiopharmaceutical: [18F]-FLT | Adult dose: (0.15 mCi/kg ranging from 3 to 16 mCi), route = IV, Time interval between administration and scanning: 60 +/- 10minutes post-injection. |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2010-10-18
- Last updated
- 2017-07-02
- Results posted
- 2017-07-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01222416. Inclusion in this directory is not an endorsement.